Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Clinical trial NCT06177067 · RECRUITING

Trial details

NCT number: NCT06177067
Sponsor: St. Jude Children's Research Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Acute Myeloid Leukemia Relapsed Acute Myeloid Leukemia Acute Leukemia of Ambiguous Lineage

Start date: 2024-04-19
Primary completion: 2026-10-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.